IV Lidocaine Has No Meaningful Impact in Fibromyalgia

This article originally appeared here.
Share this content:
IV Lidocaine Has No Meaningful Impact in Fibromyalgia
IV Lidocaine Has No Meaningful Impact in Fibromyalgia

MONDAY, June 20, 2016 (HealthDay News) -- For patients with fibromyalgia, use of intravenous lidocaine has no meaningful impact, according to a study published online June 16 in the International Journal of Rheumatic Diseases.

Ana Laura Albertoni Giraldes, M.D., from the Federal University of São Paulo in Brazil, and colleagues conducted a randomized trial involving patients with fibromyalgia. Participants were randomized to receive lidocaine in saline solution or saline solution once a week for four weeks. All patients received amitriptyline for eight weeks. Patients underwent pain assessment, completed the fibromyalgia impact questionnaire, and had levels of interleukins (IL) 1, 6, and 8 measured before and after treatment.

The researchers found that the lidocaine group had lower pain intensity at week two of treatment, but not at other time points assessed during eight weeks. Both groups experienced a reduction in pain intensity at eight weeks after the start of treatment. There was no difference between the groups in use of acetaminophen and tramadol, or in plasma levels of IL-1, -6, and -8. There was no difference between the groups in clinical manifestations or side effects.

"The combination of 240 mg of intravenous lidocaine (once a week for four weeks) with 25 mg of amitriptyline for eight weeks had no meaningful impact in fibromyalgia patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Ad Campaign Hopes to Halt E-Cigarette Use Among Teens

FDA Ad Campaign Hopes to Halt E-Cigarette Use ...

'The Real Cost' Youth E-Cigarette Prevention Campaign to target at-risk youth

U.S. Senate Passes Opioids Bill

U.S. Senate Passes Opioids Bill

Comprehensive bipartisan package earmarks billions of dollars to fight opioid abuse in the United States

Active Choice Intervention Tied to Increase in Flu Shot Rates

Active Choice Intervention Tied to Increase in Flu ...

Vaccination rates decrease throughout the day; with intervention, similar increase throughout day

is free, fast, and customized just for you!




Already a member?

Sign In Now »